Abstract
Aim: To determine the utility of deaminated gliadin peptide IgG antibodies (DGP-IgG) as a replacement for endomysial antibodies to diagnose coeliac disease in children with a tissue transglutaminase IgA antibodies (tTG-IgA) ≥10× upper limit of normal (ULN).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
